Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jas Bindra"'
Publikováno v:
Journal of Health Economics and Outcomes Research (2022)
**Background:** Sarcoidosis, an inflammatory systemic granulomatous disease, affects multiple organs and has a diverse clinical course. Repository corticotropin injection (RCI) is an effective treatment for advanced symptomatic sarcoidosis. Since sar
Externí odkaz:
https://doaj.org/article/57fd2b3299684d278ea115927b9e7e73
Publikováno v:
Advances in Therapy. 40:194-210
Despite current standard of care (SoC), there is an unmet need for the treatment of active systemic lupus erythematosus (SLE). The study assessed the cost-effectiveness of ActharCost-effectiveness model was developed using a probabilistic cohort-leve
Publikováno v:
ClinicoEconomics and Outcomes Research: CEOR
Samuel F Hunter,1 Jas Bindra,2 Ishveen Chopra,3 John Niewoehner,4 Mary P Panaccio,4 George J Wan4 1Advanced Neurosciences Institute, Franklin, TN, USA; 2Falcon Research Group, North Potomac, MD, USA; 3Manticore Consultancy, Bethesda, MD, USA; 4Mallin
Publikováno v:
ClinicoEconomics and Outcomes Research: CEOR
Jas Bindra,1 Ishveen Chopra,2 John Niewoehner,3 Mary Panaccio,3 George J Wan3 1Falcon Research Group, North Potomac, MD, USA; 2Manticore Consultancy, Bethesda, MD, USA; 3Mallinckrodt Pharmaceuticals, Hampton, NJ, USACorrespondence: George J WanMallin
Autor:
Bindra, Jas (AUTHOR), Chopra, Ishveen (AUTHOR), Hayes, Kyle (AUTHOR), Niewoehner, John (AUTHOR), Panaccio, Mary Prince (AUTHOR), Wan, George J (AUTHOR)
Publikováno v:
Therapeutics & Clinical Risk Management. Feb2024, Vol. 20, p83-94. 12p.
Publikováno v:
Advances in Therapy; Dec2023, Vol. 40 Issue 12, p5432-5446, 15p
Publikováno v:
Advances in Therapy; Jan2023, Vol. 40 Issue 1, p194-210, 17p